These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11152398)

  • 21. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
    Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
    Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetically engineered single-gene-encoded anti-TAG72 chimeric antibody secreted from myeloma cells.
    Qi Y; Xiang J
    Hum Antibodies Hybridomas; 1995; 6(4):161-6. PubMed ID: 8688499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets.
    Ching KH; Collarini EJ; Abdiche YN; Bedinger D; Pedersen D; Izquierdo S; Harriman R; Zhu L; Etches RJ; van de Lavoir MC; Harriman WD; Leighton PA
    MAbs; 2018 Jan; 10(1):71-80. PubMed ID: 29035625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Construction and expression of anti-tumor necrosis factor related apoptosis-inducing ligand receptor death receptor 5 chimeric antibody in eukaryotic cells].
    Chen F; Guo YB; Liu SL; Zheng DX; Liu YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):690-5. PubMed ID: 19180918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the insulin-like growth factor I (IGF I) epitopes recognized by monoclonal and polyclonal antibodies to IGF I.
    Cascieri MA; Bayne ML; Ber E; Green BG; Men GW; Chicchi GG
    Endocrinology; 1990 Jun; 126(6):2773-7. PubMed ID: 1693561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
    Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of engineered antibodies.
    Hwang WY; Foote J
    Methods; 2005 May; 36(1):3-10. PubMed ID: 15848070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
    Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
    Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.
    Haidar JN; Yuan QA; Zeng L; Snavely M; Luna X; Zhang H; Zhu W; Ludwig DL; Zhu Z
    Proteins; 2012 Mar; 80(3):896-912. PubMed ID: 22180101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of CXCR4 specific antibodies with elongated CDRs.
    Liu T; Liu Y; Wang Y; Hull M; Schultz PG; Wang F
    J Am Chem Soc; 2014 Jul; 136(30):10557-60. PubMed ID: 25041362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenicity and immunogenicity of antigenized antibodies. Studies on B and T cells.
    Billetta R; Zanetti M
    Int Rev Immunol; 1993; 10(2-3):251-63. PubMed ID: 7689625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising fusion protein design to target the U87 MG glioma cell line.
    Jing C; Yuan L; Xingguo P; Zhijie H; Zai-xi C; Ru Z; Jian Y
    Asian Pac J Cancer Prev; 2011; 12(4):935-7. PubMed ID: 21790229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humanization of chimeric anti-CD20 antibody by logical and bioinformatics approach with retention of biological activity.
    Khoo YL; Cheah SH; Chong H
    Immunotherapy; 2017 Jun; 9(7):567-577. PubMed ID: 28595518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kabat Database and its applications: future directions.
    Johnson G; Wu TT
    Nucleic Acids Res; 2001 Jan; 29(1):205-6. PubMed ID: 11125092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dissection of specificity and affinity of an antibody for its specific antigen].
    Tsumoto K
    Seikagaku; 2006 Feb; 78(2):93-109. PubMed ID: 16541800
    [No Abstract]   [Full Text] [Related]  

  • 39. Identifying the Epitope Regions of Therapeutic Antibodies Based on Structure Descriptors.
    Qiu J; Qiu T; Huang Y; Cao Z
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody engineering for therapeutics.
    Presta L
    Curr Opin Struct Biol; 2003 Aug; 13(4):519-25. PubMed ID: 12948783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.